The Discounted Cash Flow (DCF) valuation of Neuropace Inc (NPCE) is (12.95) USD. With the latest stock price at 9.89 USD, the upside of Neuropace Inc based on DCF is -230.9%.
Based on the latest price of 9.89 USD and our DCF valuation, Neuropace Inc (NPCE) is a sell. selling NPCE stocks now will result in a potential gain of 230.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.9% - 9.3% | 8.1% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (25.66) - (9.11) | (12.95) |
| Upside | -359.5% - -192.1% | -230.9% |